Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 21
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The taming of PARP1 and its impact on NAD+ metabolism

  • Hurtado-Bagès, Sarah, 1990-
  • Knobloch, Gunnar
  • Ladurner, Andreas G.
  • Buschbeck, Marcus
Background: Poly-ADP-ribose polymerases (PARPs) are key mediators of cellular stress response. They are intimately linked to cellular metabolism through the consumption of NAD+. PARP1/ARTD1 in the nucleus is the major NAD+ consuming activity and plays a key role in maintaining genomic integrity. Scope of review: In this review, we discuss how different organelles are linked through NAD+ metabolism and how PARP1 activation in the nucleus can impact the function of distant organelles. We discuss how differentiated cells tame PARP1 function by upregulating an endogenous inhibitor, the histone variant macroH2A1.1. Major conclusions: The presence of macroH2A1.1, particularly in differentiated cells, raises the threshold for the activation of PARP1 with consequences for DNA repair, gene transcription, and NAD+ homeostasis., Research in the Ladurner and Buschbeck labs was supported by the following grants: the Deutsche Forschungsgemeinschaft SFB 646 and SFB 1064 collaborative research centers (to AGL); the Deutsche Forschungsgemeinschaft CIPSM and SyNergy research excellence clusters (to AGL); the Bavarian BioSysNet Program (to AGL); the ERA-NET Neuron project Food4Thought funded by the Bundesministerium für Bildung und Forschung (to AGL); the Marie Skłodowska Curie Training network “ChroMe” H2020-MSCA-ITN-2015-675,610 (to MB and AGL); MINECO RTI2018-094005-B-I00 (to MB); MINECO-ISCIII PIE16/00011 (to MB); the Deutsche José Carreras Leukaemie Stiftung DJCLS 14R/2018 (to MB); AGAUR 2017-SGR-305 (to MB); and Fundació La Marató de TV3 257/C/2019 (to MB). Research at the IJC is supported by the La Caixa Foundation, the Fundació Internacional Josep Carreras, Celgene Spain, and the CERCA Program/Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Elucidating the Role of Chromatin State and Transcription Factors on the Regulation of the Yeast Metabolic Cycle: A Multi-Omic Integrative Approach

  • Sánchez-Gaya, Víctor
  • Casaní-Galdón, Salvador
  • Ugidos, Manuel
  • Kuang, Zheng
  • Mellor, Jane
  • Conesa, Ana
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] The Yeast Metabolic Cycle (YMC) is a model system in which levels of around 60% of the yeast transcripts cycle over time. The spatial and temporal resolution provided by the YMC has revealed that changes in the yeast metabolic landscape and chromatin status can be related to cycling gene expression. However, the interplay between histone modifications and transcription factor activity during the YMC is still poorly understood. Here we apply an innovative statistical approach to integrate chromatin state (ChIP-seq) and gene expression (RNA-seq) data to investigate the transcriptional control during the YMC. By using the multivariate regression models N-PLS (Partial Least Squares) and MORE (Multi-Omics REgulation) methodologies, we assessed the contribution of histone marks and transcription factors to the regulation of gene expression in the YMC. We found that H3K18ac and H3K9ac were the most important histone modifications, whereas Sfp1, Hfi1, Pip2, Mig2, and Yhp1 emerged as the most relevant transcription factors. A significant association in the co-regulation of gene expression was found between H3K18ac and the transcription factors Pip2 (involved in fatty acids metabolism), Xbp1 (cyclin implicated in the regulation of carbohydrate and amino acid metabolism), and Hfi1 (involved in the formation of the SAGA complex). These results evidence the crucial role of histone lysine acetylation levels in the regulation of gene expression in the YMC through the coordinated action of transcription factors and lysine acetyltransferases., This work has received funding from the European Union s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie Grant Agreement No 675610, from Generalitat Valenciana under the grant PROMETEO/2016/023 and from BBSRC (Biotechnology and Biological Sciences Research Council) BB/P00296X/1.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD+ consumption

  • Marjanović, Melanija Posavec
  • Hurtado-Bagès, Sarah, 1990-
  • Lassi, Maximilian
  • Varela Vázquez, Vanesa
  • Malinverni, Roberto
  • Delage, Hélène
  • Navarro, Miriam
  • Corujo García, David
  • Guberovic, Iva
  • Douet, Julien
  • Gama-Perez, Pau
  • García-Roves, Pablo M. (Pablo Miguel)
  • Ahel, Ivan
  • Ladurner, Andreas G.
  • Yanes, Oscar
  • Bouvet, Philippe
  • Suelves Esteban, Mònica
  • Teperino, Raffaele
  • Pospisilik, J. Andrew
  • Buschbeck, Marcus
Histone variants are structural components of eukaryotic chromatin that can replace replication-coupled histones in the nucleosome. The histone variant macroH2A.1.1 contains a macrodomain able to bind NAD+ derived metabolites. Here, we report that macroH2A.1.1 is rapidly induced during myogenic differentiation through a switch in alternative splicing. Importantly, myotubes lacking macroH2A.1.1 display a defect in mitochondrial respiratory capacity. We find that the metabolite-interacting macrodomain is essential for sustaining optimal mitochondrial function, but dispensable for gene regulation. Through direct binding, macroH2A.1.1 inhibits basal poly-ADP ribose polymerase 1 activity and thus reduces nuclear NAD+ consumption. Consequentially, accumulation of the NAD+ precursor NMN allows the maintenance of mitochondrial NAD+ pools critical for respiration. Our data indicate that macroH2A.1.1-containing chromatin regulates mitochondrial respiration by limiting nuclear NAD+ consumption and establishing a buffer of NAD+ precursors in differentiated cells.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González Franquesa, Alba
  • Gama-Perez, Pau
  • Kulis, Marta
  • Szczepanowska, K.
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre Pellicer, Ana
  • Fernández Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino Gené, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Duran, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramon, 1946-
  • Monsalve, Maria
  • Claret i Carles, Marc
  • Graupera i Garcia-Milà, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enriquez, Jose Antonio
  • Carracedo Álvarez, Ángel
  • Perales Losa, Carlos
  • Nogueiras, Rubén
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A
  • Yanes, Oscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Evolution of a histone variant involved in compartmental regulation of NAD metabolism

  • Guberovic, Iva
  • Hurtado-Bagès, Sarah, 1990-
  • Rivera Casas, Ciro
  • Knobloch, Gunnar
  • Malinverni, Roberto
  • Valero, Vanesa
  • Leger, Michelle M.
  • Garcia, Jesús
  • Basquin, Jerome
  • Gómez de Cedron, Marta
  • Frigolé Vivas, Marta
  • Cheema, Manjinder S.
  • Pérez, Ainhoa
  • Ausió, Juan
  • Ramírez de Molina, Ana
  • Salvatella i Giralt, Xavier
  • Ruiz Trillo, Iñaki
  • Eirin Lopez, Jose M.
  • Ladurner, Andreas G.
  • Buschbeck, Marcus
NAD metabolism is essential for all forms of life. Compartmental regulation of NAD(+) consumption, especially between the nucleus and the mitochondria, is required for energy homeostasis. However, how compartmental regulation evolved remains unclear. In the present study, we investigated the evolution of the macrodomain-containing histone variant macroH2A1.1, an integral chromatin component that limits nuclear NAD(+) consumption by inhibiting poly(ADP-ribose) polymerase 1 in vertebrate cells. We found that macroH2A originated in premetazoan protists. The crystal structure of the macroH2A macrodomain from the protist Capsaspora owczarzaki allowed us to identify highly conserved principles of ligand binding and pinpoint key residue substitutions, selected for during the evolution of the vertebrate stem lineage. Metabolic characterization of the Capsaspora lifecycle suggested that the metabolic function of macroH2A was associated with nonproliferative stages. Taken together, we provide insight into the evolution of a chromatin element involved in compartmental NAD regulation, relevant for understanding its metabolism and potential therapeutic applications. MacroH2A histone variants originated before the split of fungi and animals. ADP-ribose binding is an ancestral feature of their macrodomains and is linked to the compartmental regulation of NAD metabolism. This function was selected for during the evolution of metazoans.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolution of a histone variant involved in compartmental regulation of NAD metabolism

  • Guberovic, Iva
  • Hurtado-Bagès, Sarah
  • Rivera-Casas, Ciro
  • Knobloch, Gunnar
  • Malinverni, Roberto
  • Valero, Vanesa
  • Leger, Michelle M.
  • García, Jesús
  • Basquin, Jerome
  • Gómez de Cedrón, Marta
  • Frigolé-Vivas, Marta
  • Cheema, Manjinder S.
  • Pérez, Ainhoa
  • Ausió, Juan
  • Ramírez de Molina, Ana
  • Salvatella, Xavier
  • Ruiz-Trillo, Iñaki
  • Eirín-López, José María
  • Ladurner, Andreas G.
  • Buschbeck, Marcus
NAD metabolism is essential for all forms of life. Compartmental regulation of NAD consumption, especially between the nucleus and the mitochondria, is required for energy homeostasis. However, how compartmental regulation evolved remains unclear. In the present study, we investigated the evolution of the macrodomain-containing histone variant macroH2A1.1, an integral chromatin component that limits nuclear NAD consumption by inhibiting poly(ADP-ribose) polymerase 1 in vertebrate cells. We found that macroH2A originated in premetazoan protists. The crystal structure of the macroH2A macrodomain from the protist Capsaspora owczarzaki allowed us to identify highly conserved principles of ligand binding and pinpoint key residue substitutions, selected for during the evolution of the vertebrate stem lineage. Metabolic characterization of the Capsaspora lifecycle suggested that the metabolic function of macroH2A was associated with nonproliferative stages. Taken together, we provide insight into the evolution of a chromatin element involved in compartmental NAD regulation, relevant for understanding its metabolism and potential therapeutic applications., For technical support, we thank the research service facilities of IJC and IGTP, the Crystallization Facility of the Max Planck Institute of Biochemistry, the ICTS NMR facility from the Scientific and Technological Centres of the University of Barcelona and Biophysics Core Facility of BMC-LMU. I.G. was a fellow of the Marie Skłodowska Curie Training network ‘ChroMe’ (H2020-MSCA-ITN-2015-675610, awarded to M.B. and A.G.L.). The project was further supported by national grants (nos. RTI2018-094005-B-I00 and BFU2015-66559-P from FEDER/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación to M.B.). Research in the participating labs was further supported by the following grants: the Marie Skłodowska Curie Training network ‘INTERCEPT-MDS’ no. H2020-MSCA-ITN-2020-953407 (to M.B.), MINECO-ISCIII no. PIE16/00011 (to M.B.); the Deutsche José Carreras Leukämie Stiftung DJCLS (no. 14R/2018 to M.B.), AGAUR (no. 2017-SGR-305 to M.B.), Fundació La Marató de TV3 (no. 257/C/2019 to M.B.), German Research Foundation Project (ID 213249687—SFB 1064 and Project ID 325871075—SFB 1309 to A.G.L.), the Spanish Ministry of Science (PID2019-110183RB-C21 to A.R.M.), Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM to A.R.M), Ramón Areces Foundation (to A.R.M.), National Science Foundation (EF-1921402 to J.M.E.L.), 2015 International Doctoral Fellowship La Caixa-Severo Ochoa (to M.F.V.), Marie Skłodowska-Curie Individual Fellowship (no. 747789 to M.M.L.), Juan de la Cierva-Incorporación (IJC2018-036657-I to M.M.L., ERC-2012-CoG-616960 to I.R.T.), MINECO (BFU2017-90114-P to I.R.T.), AGAUR (2017-SGR-324 to X.S.) and MINECO (BIO2015-70092-R and ERC-2014-CoG-648201 to X.S.). Research at the IJC is supported by the ‘La Caixa’ Foundation, Fundació Internacional Josep Carreras, Celgene Spain and the CERCA Programme/Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic data from the extinct giant rat from Tenerife (Canary Islands) points to a recent divergence from mainland relatives

  • Renom, P.
  • Dios Martínez, Antonio de
  • Civit, Sergi
  • Llovera, Laia
  • Sánchez-Gracia, Alejandro
  • Lizano, Esther
  • Rando, Juan Carlos
  • Marqués-Bonet, Tomàs
  • Kergoat, Gael J.
  • Casanovas-Vilar, Isaac
  • Lalueza-Fox, Carles
Evolution of vertebrate endemics in oceanic islands follows a predictable pattern, known as the island rule, according to which gigantism arises in originally small-sized species and dwarfism in large ones. Species of extinct insular giant rodents are known from all over the world. In the Canary Islands, two examples of giant rats, †Canariomys bravoi and †Canariomys tamarani, endemic to Tenerife and Gran Canaria, respectively, disappeared soon after human settlement. The highly derived morphological features of these insular endemic rodents hamper the reconstruction of their evolutionary histories. We have retrieved partial nuclear and mitochondrial data from †C. bravoi and used this information to explore its evolutionary affinities. The resulting dated phylogeny confidently places †C. bravoi within the African grass rat clade (Arvicanthis niloticus). The estimated divergence time, 650 000 years ago (95% higher posterior densities: 373 000-944 000), points toward an island colonization during the Günz-Mindel interglacial stage. †Canariomys bravoi ancestors would have reached the island via passive rafting and then underwent a yearly increase of mean body mass calculated between 0.0015 g and 0.0023 g; this corresponds to fast evolutionary rates (in darwins (d), ranging from 7.09 d to 2.78 d) that are well above those observed for non-insular mammals., For technical support, we thank the research service facilities of IJC and IGTP, the Crystallization Facility of the Max Planck Institute of Biochemistry, the ICTS NMR facility from the Scientific and Technological Centres of the University of Barcelona and Biophysics Core Facility of BMC-LMU. I.G. was a fellow of the Marie Skłodowska Curie Training network ‘ChroMe’ (H2020-MSCA-ITN-2015-675610, awarded to M.B. and A.G.L.). The project was further supported by national grants (nos. RTI2018-094005-B-I00 and BFU2015-66559-P from FEDER/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación to M.B.). Research in the participating labs was further supported by the following grants: the Marie Skłodowska Curie Training network ‘INTERCEPT-MDS’ no. H2020-MSCA-ITN-2020-953407 (to M.B.), MINECO-ISCIII no. PIE16/00011 (to M.B.); the Deutsche José Carreras Leukämie Stiftung DJCLS (no. 14R/2018 to M.B.), AGAUR (no. 2017-SGR-305 to M.B.), Fundació La Marató de TV3 (no. 257/C/2019 to M.B.), German Research Foundation Project (ID 213249687—SFB 1064 and Project ID 325871075—SFB 1309 to A.G.L.), the Spanish Ministry of Science (PID2019-110183RB-C21 to A.R.M.), Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM to A.R.M), Ramón Areces Foundation (to A.R.M.), National Science Foundation (EF-1921402 to J.M.E.L.), 2015 International Doctoral Fellowship La Caixa-Severo Ochoa (to M.F.V.), Marie Skłodowska-Curie Individual Fellowship (no. 747789 to M.M.L.), Juan de la Cierva-Incorporación (IJC2018-036657-I to M.M.L., ERC-2012-CoG-616960 to I.R.T.), MINECO (BFU2017-90114-P to I.R.T.), AGAUR (2017-SGR-324 to X.S.) and MINECO (BIO2015-70092-R and ERC-2014-CoG-648201 to X.S.). Research at the IJC is supported by the ‘La Caixa’ Foundation, Fundació Internacional Josep Carreras, Celgene Spain and the CERCA Programme/Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Independent phenotypic plasticity axes define distinct obesity sub-types

  • Yang, Chih-Hsiang
  • Conesa, Ana
  • Pospisilik, J. Andrew
RNA-seq data from both mouse primary islets and subcutaneous adipose tissue of the LCAT cohort, have been deposited to Gene Expression Omnibus and are publicly available under the accession codes GSE205740 and GSE205668, respectively. They are collected under the GSE205741 super-series. Gene expression and DNA methylation profiles by whole genome arrays from subcutaneous adipose tissue of the MuTHER TwinsUK cohort have been deposited to Array Express and are publicly available under the accession codes E-TABM-1140 and E-TABM-1866, respectively. Morphometric and genotypic data of the MuTHER TwinsUK cohort are available upon request at https://twinsuk.ac.uk/resources-for-researchers/access-our-data/. The MSigDB is available at http://www.gsea-msigdb.org/gsea/msigdb. Source data are provided with this paper., PERMUTE: J. Andrew Pospisilik, Ilaria Panzeri, Luca Fagnocchi, Stefanos Apostle, Timothy Triche Jr, Adelheid Lempradl, Zachary J. DeBruine, Emily Wolfrum, Zachary Madaj, Tim Gruber, Brooke Grimaldi, Andrea Parham, Mitchell J. McDonald, Joseph H. Nadeau, Ildiko Polyak, Carmen Khoo, Christine Lary, Peter D. Gluckman, Neerja Karnani, David Carey, Ruth J. F. Loos & Gabriel Seifert.-- et al., Studies in genetically ‘identical’ individuals indicate that as much as 50% of complex trait variation cannot be traced to genetics or to the environment. The mechanisms that generate this ‘unexplained’ phenotypic variation (UPV) remain largely unknown. Here, we identify neuronatin (NNAT) as a conserved factor that buffers against UPV. We find that Nnat deficiency in isogenic mice triggers the emergence of a bi-stable polyphenism, where littermates emerge into adulthood either ‘normal’ or ‘overgrown’. Mechanistically, this is mediated by an insulin-dependent overgrowth that arises from histone deacetylase (HDAC)-dependent β-cell hyperproliferation. A multi-dimensional analysis of monozygotic twin discordance reveals the existence of two patterns of human UPV, one of which (Type B) phenocopies the NNAT-buffered polyphenism identified in mice. Specifically, Type-B monozygotic co-twins exhibit coordinated increases in fat and lean mass across the body; decreased NNAT expression; increased HDAC-responsive gene signatures; and clinical outcomes linked to insulinemia. Critically, the Type-B UPV signature stratifies both childhood and adult cohorts into four metabolic states, including two phenotypically and molecularly distinct types of obesity., This work was supported by funding from the MPG, the VAI, the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 675610, the Novo Nordisk Foundation, European Foundation for the Study of Diabetes and the Danish Council for Independent Research and National Institutes of Health awards R21HG011964 and 1R01HG012444. The LCAT cohort was supported by grants from AK German Research Foundation CRC1052 (no. 209933838), project C05 and KO3512/3-1, the German Diabetes Association and the Federal Ministry of Education and Research, Germany, FKZ, 01EO1001 (Integrated Research and Treatment Center Adiposity Diseases). TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, Chronic Disease Research Foundation, Zoe Global Ltd. and the National Institute for Health Research-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González-Franquesa, Alba
  • Gama-Pérez, Pau
  • Kulis, Marta
  • Szczepanowska, Karolina
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre-Pellicer, Ana
  • Fernández-Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Durán, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramón
  • Monsalve, María
  • Claret, Marc
  • Graupera, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enríquez, José Antonio
  • Perales, José Carlos
  • Nogueiras, Rubén
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A.
  • Yanes, Óscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia-Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue., This work has been supported by Ministerio de Ciencia e Innovacion ´ (MICINN) Grant BFU2011- 24679 (P.M.G.-R.); Instituto de Salud Carlos III (ISCIII) Grant PI15/00701 (P.M.G.-R.) cofinanced by the European Regional Development Fund ‘‘A way to build Europe’‘; Government of Catalonia Support Grups de Recerca AGAUR 2017-SGR-204 (to J.C.P. and P.M.G-R.), 2017-SGR-736 (to J.I.M.-S.) and 2017-SGR-896 (to A.A.- M., M.S.-P., and R.G.). M.M. was recipient of a MINECO grant RTI2018- 093864-B-I00. O.Y. was funded by MINECO grant BFU2017-87958. M. A.K. was funded by a Medical University of Innsbruck Start Grant. M.C. was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement 725004). L. H. was funded by MINECO grants SAF2013- 45887-R, SAF2017-83813-C3-1-R (granted to Dolors Serra (DS) and L. H.), co-funded by the European Regional Development Fund, the Centro de Investigacion ´ Biom´edica en Red de Fisiopatología de la Obesidad y la Nutricion ´ (CIBEROBN) (Grant CB06/03/0001 to DS), the Government of Catalonia (2017SGR278 to DS), the Fundacio ´ La Marato ´ de TV3 (201627–30 to DS), the European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L’Or´eal-UNESCO “For Women in Science” research fellowships. P.M.G.-R. was a recipient of a Ramon y Cajal contract (RYC-2009-05158) from MICINN. A.G-F. was a recipient of “Beca de Formacio ´ de Personal Investigador de l’IDIBAPS” fellowship and she is currently supported by an unconditional donation from the Novo Nordisk Foundation (NNF) to NNF Center for Basic Metabolic Research (NNF18CC0034900). P.G-P. was a recipient of predoctoral fellowship from the Universitat de Barcelona (APIF-UB). K.S was financed through “Advanced Postdoc Grant” from SFB 1218 (DFG, German Reuter Foundation, Projektnummer 269925409). J.M-B. was a recipient of predoctoral fellowship from the European Union’s Horizon 2020 research and innovation program under the Marie SkłodowskaCurie grant agreement 675610. E.S-R. was recipient of a predoctoral fellowship from Ministerio de Economia y Empresa (MINECO) grant BES-2013-062796. This work was partially developed at the Esther Koplowitz Center (CEK, Barcelona, Spain).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González-Franquesa, A.
  • Gama-Pérez, P.
  • Kulis, M.
  • Szczepanowska, K.
  • Dahdah, N.
  • Moreno-Gómez, S.
  • Latorre Pellicer, A.
  • Fernández-Ruiz, R.
  • Aguilar-Mogas, A.
  • Hoffman, A.
  • Monelli, E.
  • Samino, S.
  • Miró-Blanch, J.
  • Oemer, G.
  • Duran, X.
  • Sánchez-Rebordelo, E.
  • Schneeberger, M.
  • Obach, M.
  • Montane, J.
  • Castellano, G.
  • Chapaprieta, V.
  • Sun, W.
  • Navarro, L.
  • Prieto, I.
  • Castaño, C.
  • Novials, A.
  • Gomis, R.
  • Monsalve, M.
  • Claret, M.
  • Graupera, M.
  • Soria, G.
  • Wolfrum, C.
  • Vendrell, J.
  • Fernández-Veledo, S.
  • Enríquez, J. A.
  • Carracedo, A.
  • Perales, J. C.
  • Nogueiras, R.
  • Herrero, L.
  • Trifunovic, A.
  • Keller, M. A.
  • Yanes, O.
  • Sales-Pardo, M.
  • Guimerà, R.
  • Blüher, M.
  • Martín-Subero, J. I.
  • García-Roves, P.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González Franquesa, Alba
  • Gama-Perez, Pau
  • Kulis, Marta
  • Szczepanowska, K.
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre Pellicer, Ana
  • Fernández Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino Gené, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Duran, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramon, 1946-
  • Monsalve, Maria
  • Claret i Carles, Marc
  • Graupera i Garcia-Milà, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enriquez, Jose Antonio
  • Carracedo Álvarez, Ángel
  • Perales Losa, Carlos
  • Nogueiras, Rubén
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A
  • Yanes, Oscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia Roves, Pablo M.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD+ consumption

  • Marjanović, Melanija Posavec
  • Hurtado-Bagès, Sarah, 1990-
  • Lassi, Maximilian
  • Varela Vázquez, Vanesa
  • Malinverni, Roberto
  • Delage, Hélène
  • Navarro, Miriam
  • Corujo García, David
  • Guberovic, Iva
  • Douet, Julien
  • Gama-Perez, Pau
  • García-Roves, Pablo M. (Pablo Miguel)
  • Ahel, Ivan
  • Ladurner, Andreas G.
  • Yanes, Oscar
  • Bouvet, Philippe
  • Suelves Esteban, Mònica
  • Teperino, Raffaele
  • Pospisilik, J. Andrew
  • Buschbeck, Marcus
Histone variants are structural components of eukaryotic chromatin that can replace replication-coupled histones in the nucleosome. The histone variant macroH2A.1.1 contains a macrodomain able to bind NAD+ derived metabolites. Here, we report that macroH2A.1.1 is rapidly induced during myogenic differentiation through a switch in alternative splicing. Importantly, myotubes lacking macroH2A.1.1 display a defect in mitochondrial respiratory capacity. We find that the metabolite-interacting macrodomain is essential for sustaining optimal mitochondrial function, but dispensable for gene regulation. Through direct binding, macroH2A.1.1 inhibits basal poly-ADP ribose polymerase 1 activity and thus reduces nuclear NAD+ consumption. Consequentially, accumulation of the NAD+ precursor NMN allows the maintenance of mitochondrial NAD+ pools critical for respiration. Our data indicate that macroH2A.1.1-containing chromatin regulates mitochondrial respiration by limiting nuclear NAD+ consumption and establishing a buffer of NAD+ precursors in differentiated cells.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Evolution of a histone variant involved in compartmental regulation of NAD metabolism

  • Guberovic, Iva
  • Hurtado-Bagès, Sarah, 1990-
  • Rivera Casas, Ciro
  • Knobloch, Gunnar
  • Malinverni, Roberto
  • Valero, Vanesa
  • Leger, Michelle M.
  • Garcia, Jesús
  • Basquin, Jerome
  • Gómez de Cedron, Marta
  • Frigolé Vivas, Marta
  • Cheema, Manjinder S.
  • Pérez, Ainhoa
  • Ausió, Juan
  • Ramírez de Molina, Ana
  • Salvatella i Giralt, Xavier
  • Ruiz Trillo, Iñaki
  • Eirin Lopez, Jose M.
  • Ladurner, Andreas G.
  • Buschbeck, Marcus
NAD metabolism is essential for all forms of life. Compartmental regulation of NAD(+) consumption, especially between the nucleus and the mitochondria, is required for energy homeostasis. However, how compartmental regulation evolved remains unclear. In the present study, we investigated the evolution of the macrodomain-containing histone variant macroH2A1.1, an integral chromatin component that limits nuclear NAD(+) consumption by inhibiting poly(ADP-ribose) polymerase 1 in vertebrate cells. We found that macroH2A originated in premetazoan protists. The crystal structure of the macroH2A macrodomain from the protist Capsaspora owczarzaki allowed us to identify highly conserved principles of ligand binding and pinpoint key residue substitutions, selected for during the evolution of the vertebrate stem lineage. Metabolic characterization of the Capsaspora lifecycle suggested that the metabolic function of macroH2A was associated with nonproliferative stages. Taken together, we provide insight into the evolution of a chromatin element involved in compartmental NAD regulation, relevant for understanding its metabolism and potential therapeutic applications. MacroH2A histone variants originated before the split of fungi and animals. ADP-ribose binding is an ancestral feature of their macrodomains and is linked to the compartmental regulation of NAD metabolism. This function was selected for during the evolution of metazoans.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The taming of PARP1 and its impact on NAD+ metabolism

  • Hurtado-Bagès, Sarah, 1990-
  • Knobloch, Gunnar
  • Ladurner, Andreas G.
  • Buschbeck, Marcus
Background: Poly-ADP-ribose polymerases (PARPs) are key mediators of cellular stress response. They are intimately linked to cellular metabolism through the consumption of NAD+. PARP1/ARTD1 in the nucleus is the major NAD+ consuming activity and plays a key role in maintaining genomic integrity. Scope of review: In this review, we discuss how different organelles are linked through NAD+ metabolism and how PARP1 activation in the nucleus can impact the function of distant organelles. We discuss how differentiated cells tame PARP1 function by upregulating an endogenous inhibitor, the histone variant macroH2A1.1. Major conclusions: The presence of macroH2A1.1, particularly in differentiated cells, raises the threshold for the activation of PARP1 with consequences for DNA repair, gene transcription, and NAD+ homeostasis., Research in the Ladurner and Buschbeck labs was supported by the following grants: the Deutsche Forschungsgemeinschaft SFB 646 and SFB 1064 collaborative research centers (to AGL); the Deutsche Forschungsgemeinschaft CIPSM and SyNergy research excellence clusters (to AGL); the Bavarian BioSysNet Program (to AGL); the ERA-NET Neuron project Food4Thought funded by the Bundesministerium für Bildung und Forschung (to AGL); the Marie Skłodowska Curie Training network “ChroMe” H2020-MSCA-ITN-2015-675,610 (to MB and AGL); MINECO RTI2018-094005-B-I00 (to MB); MINECO-ISCIII PIE16/00011 (to MB); the Deutsche José Carreras Leukaemie Stiftung DJCLS 14R/2018 (to MB); AGAUR 2017-SGR-305 (to MB); and Fundació La Marató de TV3 257/C/2019 (to MB). Research at the IJC is supported by the La Caixa Foundation, the Fundació Internacional Josep Carreras, Celgene Spain, and the CERCA Program/Generalitat de Catalunya.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers

  • Diesch, Jeannine|||0000-0002-4667-3468
  • Zwick, Anabel
  • Garz, Anne-Kathrin
  • Palau de Miguel, Anna|||0000-0003-2131-1265
  • Buschbeck, Marcus|||0000-0002-3218-4567
  • Götze, Katharina S.|||0000-0002-6276-8002
The azanucleosides azacitidine and decitabine are currently used for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) in patients not only eligible for intensive chemotherapy but are also being explored in other hematologic and solid cancers. Based on their capacity to interfere with the DNA methylation machinery, these drugs are also referred to as hypomethylating agents (HMAs). As DNA methylation contributes to epigenetic regulation, azanucleosides are further considered to be among the first true "epigenetic drugs" that have reached clinical application. However, intriguing new evidence suggests that DNA hypomethylation is not the only mechanism of action for these drugs. This review summarizes the experience from more than 10 years of clinical practice with azanucleosides and discusses their molecular actions, including several not related to DNA methylation. A particular focus is placed on possible causes of primary and acquired resistances to azanucleoside treatment. We highlight current limitations for the success and durability of azanucleoside-based therapy and illustrate that a better understanding of the molecular determinants of drug response holds great potential to overcome resistance.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD + consumption

  • Posavec Marjanović, Melanija
  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Lassi, Maximilian
  • Valero, Vanesa
  • Malinverni, Roberto|||0000-0002-0113-3417
  • Delage, Hélène
  • Navarro, Miriam
  • Corujo, David|||0000-0001-7930-0935
  • Guberovic, Iva
  • Douet, Julien
  • Gama-Pérez, Pau
  • Garcia-Roves, Pablo M.|||0000-0001-9826-1740
  • Ahel, Ivan
  • Ladurner, Andreas G.|||0000-0003-3835-232X
  • Yanes, Oscar|||0000-0003-3695-7157
  • Bouvet, Philippe|||0000-0003-4524-2233
  • Suelves Esteban, Mònica|||0000-0001-7095-5804
  • Teperino, Raffaele
  • Pospisilik, J. Andrew
  • Buschbeck, Marcus|||0000-0002-3218-4567
Histone variants are structural components of eukaryotic chromatin that can replace replication-coupled histones in the nucleosome. The histone variant macroH2A.1.1 contains a macrodomain able to bind NAD + derived metabolites. Here, we report that macroH2A.1.1 is rapidly induced during myogenic differentiation through a switch in alternative splicing. Importantly, myotubes lacking macroH2A.1.1 display a defect in mitochondrial respiratory capacity. We find that the metabolite-interacting macrodomain is essential for sustaining optimal mitochondrial function, but dispensable for gene regulation. Through direct binding, macroH2A.1.1 inhibits basal poly-ADP ribose polymerase 1 activity and thus reduces nuclear NAD+ consumption. Consequentially, accumulation of the NAD + precursor NMN allows the maintenance of mitochondrial NAD + pools critical for respiration. Our data indicate that macroH2A.1.1-containing chromatin regulates mitochondrial respiration by limiting nuclear NAD+ consumption and establishing a buffer of NAD + precursors in differentiated cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Post-Translational Modifications of H2A Histone Variants and Their Role in Cancer

  • Corujo, David|||0000-0001-7930-0935
  • Buschbeck, Marcus|||0000-0002-3218-4567
Histone variants are chromatin components that replace replication-coupled histones in a fraction of nucleosomes and confer particular characteristics to chromatin. H2A variants represent the most numerous and diverse group among histone protein families. In the nucleosomal structure, H2A-H2B dimers can be removed and exchanged more easily than the stable H3-H4 core. The unstructured N-terminal histone tails of all histones, but also the C-terminal tails of H2A histones protrude out of the compact structure of the nucleosome core. These accessible tails are the preferential target sites for a large number of post-translational modifications (PTMs). While some PTMs are shared between replication-coupled H2A and H2A variants, many modifications are limited to a specific histone variant. The present review focuses on the H2A variants H2A.Z, H2A.X, and macroH2A, and summarizes their functions in chromatin and how these are linked to cancer development and progression. H2A.Z primarily acts as an oncogene and macroH2A and H2A.X as tumour suppressors. We further focus on the regulation by PTMs, which helps to understand a degree of context dependency.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

The taming of PARP1 and its impact on NAD+ metabolism

  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Knobloch, G.
  • Ladurner, Andreas G.|||0000-0003-3835-232X
  • Buschbeck, Marcus|||0000-0002-3218-4567
Background: Poly-ADP-ribose polymerases (PARPs) are key mediators of cellular stress response. They are intimately linked to cellular metabolism through the consumption of NAD. PARP1/ARTD1 in the nucleus is the major NAD consuming activity and plays a key role in maintaining genomic integrity. Scope of review: In this review, we discuss how different organelles are linked through NAD metabolism and how PARP1 activation in the nucleus can impact the function of distant organelles. We discuss how differentiated cells tame PARP1 function by upregulating an endogenous inhibitor, the histone variant macroH2A1.1. Major conclusions: The presence of macroH2A1.1, particularly in differentiated cells, raises the threshold for the activation of PARP1 with consequences for DNA repair, gene transcription, and NAD homeostasis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Histone Variant MacroH2A1 Regulates Key Genes for Myogenic Cell Fusion in a Splice-Isoform Dependent Manner

  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Posavec Marjanovic, Melanija
  • Valero, Vanesa
  • Malinverni, Roberto|||0000-0002-0113-3417
  • Corujo, David|||0000-0001-7930-0935
  • Bouvet, Philippe|||0000-0003-4524-2233
  • Lavigne, A. C.|||0000-0001-9389-7029
  • Bystricky, K.|||0000-0001-6717-3721
  • Buschbeck, Marcus|||0000-0002-3218-4567
MacroH2A histone variants have functions in differentiation, somatic cell reprogramming and cancer. However, at present, it is not clear how macroH2As affect gene regulation to exert these functions. We have parted from the initial observation that loss of total macroH2A1 led to a change in the morphology of murine myotubes differentiated ex vivo. The fusion of myoblasts to myotubes is a key process in embryonic myogenesis and highly relevant for muscle regeneration after acute or chronic injury. We have focused on this physiological process, to investigate the functions of the two splice isoforms of macroH2A1. Individual perturbation of the two isoforms in myotubes forming in vitro from myogenic C2C12 cells showed an opposing phenotype, with macroH2A1.1 enhancing, and macroH2A1.2 reducing, fusion. Differential regulation of a subset of fusion-related genes encoding components of the extracellular matrix and cell surface receptors for adhesion correlated with these phenotypes. We describe, for the first time, splice isoform-specific phenotypes for the histone variant macroH2A1 in a physiologic process and provide evidence for a novel underlying molecular mechanism of gene regulation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

The MacroH2A1.1 - PARP1 Axis at the Intersection Between Stress Response and Metabolism

  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Guberovic, Iva
  • Buschbeck, Marcus|||0000-0002-3218-4567
The exchange of replication-coupled canonical histones by histone variants endows chromatin with specific features. The replacement of the canonical H2A histone for the histone variant macroH2A is one of the most remarkable epigenetic modifications. The three vertebrate macroH2A proteins have a unique tripartite structure consisting of H2A-like domain, unstructured linker, and macrodomain. Macrodomains are ancient globular folds that are able to bind nicotinamide adenine dinucleotide (NAD +) derived metabolites. Here, we will briefly describe the physiological relevance of the metabolite binding in the context of chromatin. In particular, we will focus on the macroH2A1.1 isoform that binds ADP-ribose and poly-ADP-ribose polymerase 1 (PARP1) enzyme, a cellular stress sensor. We will discuss the impact of this interaction in the context of cancer, senescence, cell stress and energy metabolism.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetics in a spectrum of myeloid diseases and its exploitation for therapy

  • Maher, Michael|||0000-0002-4956-7185
  • Diesch, Jeannine|||0000-0002-4667-3468
  • Le Pannérer, Marguerite Marie|||0000-0002-5779-8805
  • Buschbeck, Marcus|||0000-0002-3218-4567
Mutations in genes encoding chromatin regulators are early events contributing to de-veloping asymptomatic clonal hematopoiesis of indeterminate potential and its frequent progression to myeloid diseases with increasing severity. We focus on the subset of myeloid diseases encompassing myelodysplastic syndromes and their transformation to secondary acute myeloid leukemia. We introduce the major concepts of chromatin regulation that provide the basis of epigenetic regulation. In greater detail, we discuss those chromatin regulators that are frequently mutated in myelodysplastic syndromes. We discuss their role in the epigenetic regulation of normal hematopoiesis and the consequence of their mutation. Finally, we provide an update on the drugs interfering with chromatin regulation approved or in development for myelodysplastic syndromes and acute myeloid leukemia.